Search Results for "Protox Tsx"
Original Source: Protox Therapeutics Inc.
Protox Therapeutics is a product-focused development-stage company and a leader in advancing novel, targeted protein toxin therapeutics for the treatment of cancer and other proliferative diseases. Through the company’s INxin™ and PORxin™ technology platforms, therapeutic candidates are generated by engineering the naturally occurring toxins, Pseudomonas exotoxin and proaerolysin. These drugs are potent anti-cancer agents with distinct modes of action.INxin™ drugs target cancer cells that produce sp...
Matching Channels
None
Matching News
Sophiris Bio Inc. (TSX:SHS) hired Randall Woods as CEO. Woods is the former president and CEO of NovaCardia Inc., which Merck & Co. Inc. (NYSE:MRK) acquired in 2007. Sophiris (formerly Protox Therape...
Matching PubMed Articles
Protoporphyrinogen oxidase (Protox) catalyses the oxidation of protoporphyrinogen IX to protoporphyrin IX during the synthesis of tetrapyrrole molecules. Protox is encoded by the hemY gene in eukaryot...
Gene flow from herbicide-tolerant GM rice and the heterosis of GM rice-weed F2 progeny.
Gene flow from genetically modified (GM) crops to non-GM cultivars or weedy relatives may lead to the development of more aggressive weeds. We quantified the amount of gene flow from herbicide-toleran...
